A cDNA library prepared from human placenta was screened for sequences encoding the placental protein 4 (PP4). PP4 is an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade. Partial amino acid sequence information from PP4-derived cyanogen bromide fragments was used to design three oligonucleotide probes for screening the library. From 106 independent recombinants, 18 clones were identified that hybridized to all three probes. These 18 recombinants contained cDNA inserts encoding a protein of 320 amino acid residues. In addition to the PP4 cDNA we identified 9 other recombinants encoding a protein with considerable similarity (74%) to PP4, which was termed PP4-X. PP4 and PP4-X belong to the lipocortin family, as judged by their homology to lipocortin I and calpactin I.
The protein PP4 was first described by Bohn et al. (1) as a placental protein (Mr, 35,000), which is mainly found in the placental tissue (50 mg per placenta) with very little secretion into the maternal bloodstream (2 ,ug/liter). Subsequently, the protein PP4 was shown to be an anticoagulant protein that appeared to be a potent inhibitor of thromboplastin and immunologically identical or related to the thromboplastin inhibitor described by Shidara (2) . It binds specifically to phospholipid membranes and inhibits the blood coagulation cascade by preventing formation of the extrinsic pathway activator, which consists of phospholipid, thromboplastin (FIII), and FVII in the presence of Ca2" (3) . A thromboplastin inhibitor prevents blood coagulation without proteolytic inactivation and prolongs the thromboplastin-induced clotting time, but it does not influence the thrombindependent fibrin formation. Nearly the same anticoagulatory mechanism was described for a protein of Mr 32,000 isolated from arteries of human umbilical cord (4) . An increased serum level ofPP4 has been reported for patients with cardiac infarction as well as in tumor tissues such as serous and mucinous cystadenocarcinomas (5, 6) . These findings suggest that PP4 could serve as a diagnostic marker. Partial amino acid sequences of PP4 showed a striking similarity to proteins of the phospholipase A2 inhibitor family-e.g., lipocortin I and calpactin I. These proteins are thought to block production of the mediators of inflammation (prostaglandins and leukotrienes) by inhibiting the release of arachidonic acid from membranes by phospholipase A2 (7) . Lipocortin I and calpactin I (or lipocortin II) are the first identified members of the family, but calelectrin, endonexin, and some other proteins of apparent M, 32,000-38,000 also belong to this class (8) (9) (10) (11) (12) . Human lipocortin I is defined as an anti-inflammatory protein that is inducible by glucocorticoids. It can be phosphorylated by tyrosine and serinethreonine kinases (13) . Recently, it was shown that lipocortin I has the same inhibitory profile as the glucocorticoids but with a more rapid onset of action (14) . Lipocortin I exists as a monomeric protein. On the other hand, calpactin I was isolated as a monomer as well as a heterologous tetramer of two large subunits (Mr, 36,000) and two small subunits (Mr, 10 ,000) (15) . It acts on the cytoskeletal proteins spectrin and actin, binds phospholipid in a Ca2 -dependent manner, and is a major substrate for tyrosine-protein kinases (16) . Both proteins, lipocortin I and calpactin I from humans, occur in placenta at -0.2% of the total protein (7). Analysis of the amino acid sequence of both proteins revealed four internal repeating units of 70 amino acids each (7, 9, 17 Isolation of RNA and Preparation of cDNA Libraries. RNA was prepared from a mature human placenta by the standard guanidinium thiocyanate extraction procedure (19) . Poly(A)+ RNA was selected by oligo(dT)-cellulose chromatography (20) and 4 ,ug was copied into cDNA with reverse transcriptase; double-stranded cDNA was prepared by the method of Gubler and Hoffman (21) . After EcoRI linker addition, the cDNA was ligated into the AgtlO vector as described (22) bromide fragments. Sequence analysis was performed on an Applied Biosystems 470A gas-phase sequencer. We chose the oligonucleotide sequence 5' ATGAAGGGCC TGGGC-ACAGA TGAGGAGAGC ATCCT 3' (probe I) for the peptide sequence Met-Lys-Gly-Leu-Gly-Thr-Asp-Glu-GluSer-Ile-Leu, 5 ' CAGGAGATCT CTGCTGCCTT CAA-GACCCTG TTJ2GGC 3' (probe II) for Gln-Glu-Ile-Ser-AlaAla-Phe-Lys-Thr-Leu-Phe-Gly, and 5' GACCCTGATG CTGGCATTGA TGAGGCCCAG GTGGAGCAGG ATGCCCAG 3' (probe III) for Asp-Pro-Asp-Ala-Gly-IleAsp-Glu-Ala-Gln-Val-Glu-Gln-Asp-Ala-Gln according to the rules of Lathe (23) . For hybridization the blotted filters were hybridized and washed as described at the calculated temperature (22, 23) .
Characterization of cDNA Inserts. Recombinant phages were plaque-purified and grown in liquid culture, and phage DNA was extracted as described (22) . cDNA inserts were characterized by restriction enzyme analysis and the sequence was determined by the dideoxy sequencing strategy of Sanger et al. (24) 
RESULTS
Isolation of Human PP4 cDNA. Hybridization of the complete placental cDNA library with PP4-derived oligonucleotide probe I yielded 46 positive recombinant plaques on duplicate filters (25) . By sequence analysis, we found that 9 had inserts that represent coding sequences for a similar, but not identical, protein to PP4, which we named PP4-X. Therefore, we rescreened the 46 positive phages separately with two newly designed oligonucleotide probes derived from the PP4 amino acid sequence (probes II and III). Both probes hybridized to 18 of the positives, which were different from PP4-X cDNA-containing phages. Phage DNA from three phages was isolated and digested with EcoRI, and the size of the cDNA inserts was analyzed by agarose gel electrophoresis. Each of the phages had one single EcoRI fragment ranging from 1000 to 1660 base pairs (Fig. 1) . The cDNA insert of phage PP4-14 was used to rescreen the 46 recombinant phages. Again, all 18 phages that had hybridized to probes II and III showed positive signals. cDNA of PP4-20 was sequenced and a 5'-terminal synthetic oligonucleotide probe derived from PP4-20 was used to identify inserts with maximal 5' sequence information. Two phages were identified (PP4-26 and -48). Both cDNA-specific inserts had identical 5' termini, but with a different length of the poly(A) tail, and therefore are probably derived from different cDNA molecules. In total, of the 18 isolated positives, 4 cDNA inserts were identified that carry the complete protein coding sequence of PP4 including the poly(A) sequence, of which PP4-26 has the longest sequence.
Identification of PP4-Specific mRNA. The size of the PP4 mRNA from different tissues was determined by RNA blot analysis. Poly(A)+ RNA from human liver, kidney, and placenta was separated in an agarose gel containing formaldehyde, blotted onto nitrocellulose filters, and hybridized to the 32P-labeled cDNA insert of (Fig. 2) . Placental poly(A)+ RNA showed the strongest signal while 1/5th to 1/10th the mRNA was detected in liver and kidney cells. The size of the single RNA band (=1700 nucleotides) is in good agreement with the size of the cDNA insert of PP4-26 (1660 nucleotides).
Analysis of cDNA and Deduced Amino Acid Sequence. After subcloning into the Bluescript M13 vector (Stratagene), the complete nucleotide sequence ofPP4 cDNA was determined. The nucleotide sequence as determined from clones PP4-14, -20, -26, and -48 is displayed in Fig. 3 including the deduced amino acid sequence. All four clones showed identical sequences; however, one of the clones (PP4-20) contained cytosine at nucleotide position 214, which would result in an amino acid change from glutamic acid to glutamine at amino acid position 22. The cDNA contains an open reading frame encoding a protein of 320 amino acids. Assuming the first AUG is the initiator codon the predicted molecular weight of PP4 is 35,935 (including initiator methionine).
Similar to PP4-X and lipocortin I, the first two amino acids are methionine and alanine. The protein does not contain N-linked glycosylation sites and has only one cysteine residue at the C-terminal end (position 316). Upstream of the initiator codon, the cDNA carries another 150 nucleotides. The 3' untranslated region contains 550 nucleotides, including the stop codon at position 1111, a poly(A) tail of 78 residues, and the poly(A) addition site AATAAA 17 nucleotides from the start of the poly(A) tail.
The deduced amino acid sequence reveals the presence of four internal repeat units of -70 amino acids in a similar fashion as demonstrated for lipocortin I and calpactin I (11, 17, 26) . Computer analysis of the amino acid sequence for hydrophobicity according to Kyte and Doolittle (27) shows that the repeat units carry stretches of hydrophobic amino 
510 530 550 570 . (Fig. 4) The PP4 cDNA contains only one large open reading frame with a stop codon four codons upstream of the initiator codon. Protein sequence analysis of PP4 showed that its amino terminus is blocked. Since an alanine residue follows the initiator methionine, one might assume that the first methionine of PP4 is cleaved off and the following alanine residue is modified by N-acetylation. Similar situations have been observed for lipocortin I, calpactin I, PP4-X, and factor XIIIa (8, 9, 22, 25, 26) . As in the case with these proteins, the cDNA for PP4 does not encode a signal peptide. All of these proteins, however, are secreted through the cellular membrane by a mechanism yet to be established.
ACAGAAAITATTGCTTCAAGGACACCTGAAGAACTGAGAGCCATCAAACAAGTTTATGAAGAAGAATATGGCTCAAGCCTGGAAGATGACGTGGTGGGGGACACTTCAGGGTACTACCAG T E I I A S R T P E E L R
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Comparison of the PP4 protein sequence reveals a high degree of similarity to members of the phospholipase A2 inhibitory proteins including the presence of four internal repeat units (Fig. 5) . The sequence similarity of PP4 to lipocortin I and calpactin I is 62-63% and to PP4-X it is 74%. The C-terminal part is more conserved among the proteins and most variability is seen at the very N-terminal end. PP4 is most similar to PP4-X and has nearly the same number ofamino acid residues. It also crossreacts with antiserum raised against PP4, as shown after expression of PP4-X cDNA in E. coli (25) . The biological function of the protein is not yet known. Although the similarity is only weakly retained in the amino-terminal region, there exists a potential protein kinase C phosphorylation site in PP4 at amino acid position 23 (threonine) as well as in PP4-X at position 24 and lipocortin I (26) .
Common to all members of the phospholipase A2 inhibitor family is a 4-fold repeat structure of -70 amino acid residues (28) . A consensus sequence for the repeat structures was first described by Geisow et al. (11) for calelectrin. Within the repeat structures of PP4, there are 20 residues identical or chemically related (Fig. 4) . Interestingly, the repeat units are separated by stretches of hydrophobic amino acids and another stretch of at least seven hydrophobic residues exists approximately in the middle of each repeat unit. Minor hydrophobic stretches are scattered over the whole protein sequence. A similar pattern is seen with the other proteins of the phospholipase A2 inhibitor family. The somewhat regular arrangement of hydrophobic stretches might very well have to do with the specific association ofphospholipids with these proteins. Reutelingsperger et al. (4) proposed that their anticoagulatory protein isolated from human umbilical cord, which leads in a similar fashion to a prolongation of the prothrombin time, interferes with the lipid binding of factor X and/or prothrombin.
By RNA blot analysis of poly(A)+ RNA from tissues of human origin, we could show that the PP4 mRNA has a size of -1700 nucleotides. The analysis indicates that the concentration ofPP4 mRNA is 5-10 times higher in placenta than in the other two organs. Bohn et al. (1) have shown by immunological methods that PP4 is present not only in placenta but also in different adult tissues from humans (e.g., stomach, kidney, bladder, spleen, adrenal gland, and liver). The clones PP4-26 and -48 have identical 5' ends. Although one could take this as an indication that this specifies the 5' end of the mRNA, we could not identify any sequences representing homology to the 3' end of ribosomal RNA as described by Baralle and Brownlee (29) . Within the phospholipase A2 inhibitor family the PP4 mRNA contains the most extended 3' noncoding region found so far. It is interesting that within the family the coding sequences show similarities of 50-60%, while the 5' and 3' noncoding regions show similarities of <40%.
Note Added in Proof. After submission of the manuscript, we learned about the publications by Funakoshi et al. (30) and Iwasaki et al. (31) . Both papers report on the isolation of a cDNA encoding a placental anticoagulant protein that is identical to the one described in our paper.
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